Earnings Call Insights: Axogen (AXGN) Q3 2026 Management view – “Third quarter revenue was $75.8 million, up 26.2% from third quarter 2025” and “Breast grew more than 50% year-over-year” while “extremities, OMF, head and neck combined grew 10.7%” (President, CEO & Director…
Axogen Forecasts at Least $290M 2026 Revenue, Adds $7M from Biocircuit While Planning Prostate Market Development in
Earnings Call Insights: Axogen (AXGN) Q3 2026 Management view - "Third quarter revenue was $75.8 million, up 26.2% from third quarter 2025" and "Breast grew more than 50% year-over-year" while "extremities, OMF, head and neck combined grew 10.7%" (President, CEO & Director...